CHRNA9 Antikörper
-
- Target Alle CHRNA9 Antikörper anzeigen
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHRNA9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human CHRNA9
- Isotyp
- IgG
- Top Product
- Discover our top product CHRNA9 Primärantikörper
-
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42), (N-Term) antibody
CHRNA9 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB46802 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 26-240) antibodyCHRNA9 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 139-221) antibodyCHRNA9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 8E4 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42) antibodyCHRNA9 Reaktivität: Human WB, IHC, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Maus, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Pferd, Kaninchen, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:1000 - 1:4000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Andere Bezeichnung
- CHRNA9 (CHRNA9 Produkte)
- Hintergrund
-
Synonyms: Cholinergic receptor nicotinic alpha 9,Cholinergic receptor nicotinic alpha polypeptide 9,HSA243342,MGC142109,MGC142135,NACHR alpha 9,NACHRA9,Neuronal acetylcholine receptor protein subunit alpha 9 precursor
Background: This gene is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily. It encodes a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. This protein is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea.
- Molekulargewicht
-
Observed_MW: 75kDa
Calculated_MW: 54kDa
- Gen-ID
- 55584
- UniProt
- Q9UGM1
- Pathways
- Sensory Perception of Sound
-
